University of Colorado Health Sciences Center
Aurora, Colorado, 80045-0508, United States
NCT Number: NCT00183638
This study will develop and evaluate the effectiveness of tailored web-based messages in promoting condom use among young adults.
Looking for future studies?
Notify Me18 year–25 year
All sexes
Interventional
Phase 2
Aurora, Colorado, 80045-0508, United States
Adolescents and young adults are at the greatest risk for acquiring a sexually transmitted disease (STD). Approximately 3 million people between the ages of 18 and 24 become infected with an STD each year. Education about the risks and consequences of unprotected sex is a powerful tool that can be used to prevent or reduce the risk of infection. The program in this study will deliver messages to educate participants about condom use and the risk of STD infection. The study will evaluate the effectiveness of a tailored interactive online risk reduction program versus a standard online risk reduction program in reducing the risk of STD infection in young adults.
Participants in this open-label study will be recruited from one of two clinics in the Denver, Colorado area: Denver Metropolitan Health Clinic or Planned Parenthood of the Rocky Mountains. Participants will be randomly assigned to receive internet-based messages from either the Youthnet program or the control program while filling out a risk assessment survey. Participants in the Youthnet program will be asked their gender and ethnicity so they may be assigned to a role model of the same gender and ethnicity via a computer program. This role model will appear online 5 times during the survey to deliver interactive messages that will be tailored to HIV/STD risk reduction and will specifically address attitudes about condom usage. The control program will deliver 5 general, non-tailored messages containing information on reproductive health not specific to condoms or STDs. Participants will be assessed at baseline and a follow-up session 3 months after enrollment. Frequency of condom use and attitudes toward condom use will be assessed using behavioral scales.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants will receive five 30-second flash clips promoting condom norms, positive attitudes, self-efficacy, and risk awareness. Participants in the Youthnet program will be asked their gender and ethnicity so they may be assigned to a role model of the same gender and ethnicity via a computer program. This role model will appear online 5 times during the survey to deliver interactive messages that will be tailored to HIV/STD risk reduction and will specifically address attitudes about condom usage.
Other names: Youthnet
The control program will deliver five general, non-tailored messages containing information on reproductive health not specific to condoms or STDs.
Time frame: Measured at Month 3
Time frame: Measured at Month 3
Time frame: Measured at Month 3
University of Colorado, Denver
Other
Randomized Controlled Trial to Establish Efficacy of a Website to Promote Condom Use for Adults Aged 18-25
Acronym: Youthnet
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06487390
Blood-Borne Infections, Communicable Diseases
Birmingham, Alabama, United States
View Trial DetailsNCT05541081
Bacterial Infections, Bacterial Infections and Mycoses
Harare, Zimbabwe
View Trial DetailsNCT05708014
Acquired Immunodeficiency Syndrome, Behavior
Miami, Florida, United States
View Trial DetailsNCT06600087
Blood-Borne Infections, Communicable Diseases
Bordeaux, France
View Trial Details